Respiratory Syncytial Virus Pneumonia Treated with Lower-Dose Palivizumab in a Heart Transplant Recipient

Respiratory syncytial virus (RSV) is an important community-acquired pathogen that can cause significant morbidity and mortality in patients who have compromised pulmonary function, are elderly, or are immunosuppressed. This paper describes a 70-year-old man with a remote history of heart transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Grodin, J. L., Wu, K. S., Kitchell, E. E., Le, J., Mishkin, J. D., Drazner, M. H., Markham, D. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008357/
https://www.ncbi.nlm.nih.gov/pubmed/24826271
http://dx.doi.org/10.1155/2012/723407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008357/
https://www.ncbi.nlm.nih.gov/pubmed/24826271
http://dx.doi.org/10.1155/2012/723407

Ejemplares similares